Next Level Private’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Buy
73,247
+8,093
+12% +$465K 0.83% 27
2026
Q1
$3.95M Buy
65,154
+3,927
+6% +$229K 0.89% 26
2025
Q4
$3.3M Buy
61,227
+4,927
+9% +$237K 0.87% 26
2025
Q3
$2.54M Sell
56,300
-19,299
-26% -$901K 0.74% 32
2025
Q2
$3.5M Buy
75,599
+2,365
+3% +$116K 1.14% 24
2025
Q1
$4.47M Buy
73,234
+1,079
+1% +$62.9K 1.66% 18
2024
Q4
$4.08M Buy
72,155
+144
+0.2% +$8.05K 1.65% 21
2024
Q3
$3.73M Buy
72,011
+2,905
+4% +$136K 1.53% 19
2024
Q2
$2.87M Buy
69,106
+10,183
+17% +$456K 1.31% 21
2024
Q1
$3.2M Buy
58,923
+700
+1% +$35.7K 1.47% 21
2023
Q4
$2.99M Buy
58,223
+4,412
+8% +$232K 1.69% 17
2023
Q3
$3.11M Sell
53,811
-262
-0.5% -$16.1K 2.06% 11
2023
Q2
$3.38M Buy
54,073
+1,520
+3% +$102K 2.19% 10
2023
Q1
$3.64M Buy
52,553
+354
+0.7% +$25K 2.87% 10
2022
Q4
$3.71M Buy
52,199
+31
+0.1% +$2.34K 2.73% 9
2022
Q3
$3.73M Buy
+52,168
New +$3.78M 3.28% 8
2022
Q2
Sell
-51,513
Closed -$3.76M 135
2022
Q1
$3.76M Buy
51,513
+528
+1% +$35.5K 3.04% 9
2021
Q4
$3.18M Buy
+50,985
New +$2.99M 2.67% 9

Other funds holding BMY

Next Level Private's BMY Position: Q2 2026 in Review

Next Level Private increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $465K and bringing the position to 73,247 shares worth $4.22M. The position accounts for 0.83% of the portfolio, ranked #27.

Next Level Private first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.47M in Q1 2025. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Next Level Private held 73,247 shares of Bristol-Myers Squibb worth $4.22M as of Q2 2026.
  • Next Level Private bought 8,093 Bristol-Myers Squibb shares in Q2 2026, an estimated $465K.
  • Bristol-Myers Squibb made up 0.83% of Next Level Private's portfolio in Q2 2026, its #27 holding.
  • Next Level Private first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • Next Level Private's Bristol-Myers Squibb position peaked at $4.47M in Q1 2025.
  • 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Next Level Private's 13F filing for Q2 2026, filed 9 Jul 2026.